Patents by Inventor Andrew Rynne

Andrew Rynne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
    Patent number: 5852047
    Abstract: Salicylates of esterifiable ACE-inhibitors, especially captopril-S-aspirinate, and processes for their preparation are described. Such compounds are useful as analgesics, in the process of anti-clotting and as anti-hypertensive pharmaceutical reagents.
    Type: Grant
    Filed: July 29, 1996
    Date of Patent: December 22, 1998
    Assignee: Cal International Limited
    Inventors: William Byrne, Andrew Rynne
  • Ester of an organic nitrate and a salicylate
    Patent number: 5665766
    Abstract: A pharmaceutical product for the relief of the symptoms of angina pectoris and the like comprises an ester of an organic nitrate and a salicylate or derivative thereof having anti-platelet activity.
    Type: Grant
    Filed: January 30, 1995
    Date of Patent: September 9, 1997
    Assignee: Cal International Limited
    Inventors: William Byrne, Andrew Rynne
  • Pharmaceutical composition
    Patent number: 5156849
    Abstract: A pharmaceutical product preferably in the form of a capsule comprises in one case Atenolol and aspirin. A barrier film coating including a dihydric alcohol is provided around a tablet of Atenolol which in turn is surrounded by Aspirin inside a capsule. Aspirin is preferentially and maximally absorbed in the first hour after ingestion before significant release and absorbtion of Atenolol.
    Type: Grant
    Filed: February 26, 1991
    Date of Patent: October 20, 1992
    Assignee: Byrne Rynne Holdings Limited
    Inventors: William Byrne, Andrew Rynne, Olive Corrigan